Elati Corporation provides full-service pharmaceutical support for every stage of drug discovery and development. We are a one-stop shop for pre-clinical pharmaceutical research, allowing for seamless integration and technology exchange across multiple disciplines.
Elati excels in medicinal chemistry, scale-up process chemistry, cellular and molecular biology, recombinant protein expression, analytical and bioanalytical method development, ADME/PK, in vitro and in vivo pharmacology, as well as clinical project management, consultancy, monitoring, and more.
Facilities within our international network are located within US, EU and Asia.
Our reputation has been built on the most technically demanding projects, typically directed at new biological targets and innovative pharmacologic inventions. Our team has a deep knowledge of drug discovery and development, from the stage of hit discovery to clinical registration, providing our customers with translation into a customized, scientifically- grounded, and regulatory- savvy approach for each technology challenge.
Our team of senior professionals have decades of experience in translating early leads into strategically-partnered therapeutic candidates. We offer rapid turn-around time and accelerated timelines.
Our pharmacology leaders have extensive experience in leveraging pre-clinical data to obtain financing in the private markets (we have raised $99 million in venture funding) and federal grants (we have received 135 NIH grants, totaling $80 million).